Literature DB >> 7585301

Apolipoprotein E polymorphism and dietary plasma cholesterol response.

M Tikkanen1, J K Huttunen, P E Pajukanta, P Pietinen.   

Abstract

All studies have demonstrated a strong association between plasma cholesterol and apoE phenotypes in the following order: E4/E4 > E4/E3 > E3/E3 > E3/E2. It has been thought possible that the apoE gene might be involved in the modulation of dietary plasma cholesterol responses, perhaps explaining the differences in cholesterol concentrations. Some dietary intervention studies have suggested that apoE4 individuals react to dietary change with exaggerated cholesterol responses. In one study, apoE4/E4 individuals responded by increased cholesterol reductions during low fat intake, and by increased cholesterol elevations during switchback to high fat diet. Plausible mechanisms have been postulated which could explain such differences. However, other studies have reported no differences in plasma lipid responses among apoE phenotypes. The studies cannot be directly compared because of different designs and study populations with differing apoE allele frequencies. Thus the possible role of genetic variation in the apoE gene in the modulation of dietary plasma lipid responses remains to be confirmed in prospective dietary studies, involving diets both rich and poor in fat and cholesterol.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585301

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  2 in total

Review 1.  Role of cholesterol 7alpha-hydroxylase (CYP7A1) in nutrigenetics and pharmacogenetics of cholesterol lowering.

Authors:  Jaroslav A Hubacek; Dagmar Bobkova
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

2.  APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome.

Authors:  Rosalind Fallaize; Andrew L Carvalho-Wells; Audrey C Tierney; Carmen Marin; Beata Kieć-Wilk; Aldona Dembińska-Kieć; Christian A Drevon; Catherine DeFoort; José Lopez-Miranda; Ulf Risérus; Wim H Saris; Ellen E Blaak; Helen M Roche; Julie A Lovegrove
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.